ReviewThe Korean journal of internal medicine2013
Endoscopic drainage in patients with inoperable hilar cholangiocarcinoma.
Review in The Korean journal of internal medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 18 citations in OpenAlex.
- Article
- Results of endoscopic biliary drainage in patients with malignant hilar stricture.Clinics (Sao Paulo, Brazil) · 2023Article
- Using the stent-in-stent technique to drain the right hepatic duct, passing across a 7-year-old obstructed spiral self-expandable metal stent of the left hepatic duct.Gastroenterology report · 2020Article
- Is EUS-guided drainage a suitable alternative technique in case of proximal biliary obstruction?Therapeutic advances in gastroenterology · 2017Article
- Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma.World journal of gastrointestinal endoscopy · 2015Review
- Stent placement in perihilar cholangiocarcinoma.Clinical liver disease · 2014Review
- Hepato-biliary-enteric stent drainage as palliative treatment for proximal malignant obstructive jaundice.Medical oncology (Northwood, London, England) · 2014Article
- Percutaneous transhepatic and endoscopic biliary drainage for malignant biliary tract obstruction: a meta-analysis.World journal of surgical oncology · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hilar cholangiocarcinoma has an extremely poor prognosis and is usually diagnosed at an advanced stage. Palliative management plays an important role in the treatment of patients with inoperable hilar cholangiocarcinoma. Surgical, percutaneous, and endoscopic biliary drainage are three modalities available to resolve obstructive jaundice. Plastic stents were widely used in the past; however, self-expanding metal stents (SEMS) have become popular recently due to their long patency and reduced risk of side branch obstruction, and SEMS are now the accepted treatment of choice for hilar cholangiocarcinoma. Bilateral drainage provides more normal and physiological biliary flow through the biliary ductal system than that of unilateral drainage. Unilateral drainage was preferred until recently because of its technical simplicity. But, with advancements in technology, bilateral drainage now achieves a high success rate and is the preferred treatment modality in many centers. However, the choice of unilateral or bilateral drainage is still controversial, and more studies are needed. This review focuses on the endoscopic method and discusses stent materials and types of procedures for patients with a hilar cholangiocarcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.